Common Variable Immunodeficiency Clinical Trials

45 clinical trials for Common Variable Immunodeficiency across international registries, including 9 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies — RECRUITING · PHASE2
• Peripheral Helper T-cells in Common Variable ImmunoDeficiency — RECRUITING · NA
• Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease — RECRUITING · PHASE2
• Natural History of Bronchiectasis — RECRUITING
• Hematopoietic Stem Cell Transplantation (HSCT) for Common Variable Immunodeficiency (CVID) and Other Autoimmune Manifestations of Primary Immune Regulatory Disorders (PIRD) — RECRUITING · PHASE2
• Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity — RECRUITING · PHASE2
• Usage of Spirometry in Managing IgG Therapy in CVID With Airway Disease — RECRUITING · PHASE4
• Clinical and Laboratory Online Patient- and Research Registry for Primary Immunodeficiencies of the European Society for Immunodeficiencies (ESID) — RECRUITING
• A Phase I-IIa trial on low-dose IL-2 (Aldesleukin) treatment for immunological dysregulation in common variable immunodeficiency (CVID) — RECRUITING
• Multimodal Assessment of Recovery Trajectories after Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) — NOT_YET_RECRUITING
• Senolytics Treatment of Interstitial Lung Disease in Common Variable Immunodeficiency — ACTIVE_NOT_RECRUITING · PHASE2
• Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies — ACTIVE_NOT_RECRUITING · NA
• Prediction of Portal Hypertension in Patients With CVID (CVID-pHT) — COMPLETED
• Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation — ACTIVE_NOT_RECRUITING · PHASE2
• Leniolisib for Immune Dysregulation in CVID — ACTIVE_NOT_RECRUITING · PHASE2
• A study to assess safety and tolerability, and explore efficacy of leniolisib for immune dysregulation in common variable immunodeficiency — OTHER · PHASE2
• Bronchiectasis Prevalence in Patients With Primary Humoral Immunodefiency in Champagne-Ardenne Region, France — COMPLETED · NA
• Abatacept restores immune system equilibrium — OTHER
• COVID-19 Vaccine Responses in PIDD Subjects — ACTIVE_NOT_RECRUITING
• Lymphocyte Immunophenotyping in Common Variable Immunodeficiency — COMPLETED
• Conditioning Regimen for Allogeneic Hematopoietic Stem-Cell Transplantation — COMPLETED · PHASE1
• Composition and Function of Gut Microbiota in Porto-sinusoidal Vascular Disease Associated With Variable Common Immunodeficiency — OTHER
• Subclinical infections of the respiratory tract affecting CVID patients — OTHER
• Breadth of Donor Options for People With Inherited Diseases Requiring Allogeneic Hematopoietic Stem Cell Transplant in the Era of Alternative Donor Transplants Using Post-Transplantation Cyclophosphamide — COMPLETED
• Immune System and Gut Abnormalities in Patients With Common Variable Immunodeficiency With and Without Gastrointestinal Symptoms — COMPLETED
• Pharmacokinetics (PK) and Safety of Subgam-VF in Primary Immunodeficiency Diseases — COMPLETED · PHASE3
• The Impact of Exercise on Stress, Fatigue, and Quality of Life in Individuals With Primary Immunodeficiency Disease — COMPLETED · NA
• Human IgGs and Endothelial Function in Vivo in Humans — COMPLETED · NA
• Workability, Health Literacy and Quality of Life of Patients with Common Variable Immunodeficiency Syndrome - Study Phase II — OTHER
• Workability, Health Literacy and Life Quality of Patients with Common Variable Immunodeficiency Disorders — OTHER
• Non-interventional study: evaluation of gastrointestinal complaints in patients with common variable immunodeficiency — OTHER
• STA-5326 Meslylate to Treat Gut Inflammation Associated With Common Variable Immunodeficiency — COMPLETED · PHASE1
• Bioequivalence Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Gammaplex® 10 and Gammaplex® 5% in Primary Immunodeficiency Diseases — COMPLETED · PHASE3
• "Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency — TERMINATED · PHASE2
• The Rifaximin Study in CVID — COMPLETED · PHASE4
• Randomized Study of Polyethylene-Glycol-Conjugated Interleukin 2 in Patients With Common Variable Immunodeficiency — COMPLETED · NA
• A Study to Find Out How Safe and Effective Gammaplex® is in Young People With Primary Immunodeficiency — COMPLETED · PHASE4
• Efficacy and Safety of Vivaglobin® in Previously Untreated Patients With Primary Immunodeficiency — COMPLETED · PHASE4
• Safety and Efficacy of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) — COMPLETED · PHASE3
• Efficacy and Safety of Intravenous Immunoglobulin IgPro10 in Patients With Primary Immunodeficiencies (PID) — COMPLETED · PHASE3
• Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy — COMPLETED · PHASE3
• Efficacy and Safety of Intravenous Immunoglobulin IVIG-F10 in Patients With Primary Immunodeficiencies (PID) — COMPLETED · PHASE3
• Allogeneic Bone Marrow Transplantation in Patients With Primary Immunodeficiencies — TERMINATED · NA
• Rapid Infusion of Immune Globulin Intravenous (Human) In Primary Immunodeficiency Patients — COMPLETED · PHASE3
• Specific IgG Antibody in Patients With Primary Antibody Deficiencies Treated With Subcutaneous Immunoglobulin — COMPLETED · NA

Refine this search